A database search revealed the similarity of μ-TRTX-An1a with theraphosid selleck toxins bearing the unusual huwentoxin-II-like fold. Moreover, it has been highlighted that this toxin has the KGD disintegrin motif. Therefore, some of the next steps suggested for the continuation of this study are the confirmation of the connectivity of the disulfide bridges and the evaluation of the potential
disintegrin activity. The electrophysiological experiments performed on P. americana DUM neurons allowed to show that under current-clamp conditions, μ-TRTX-An1a 1) induced a membrane depolarization, 2) enhanced the spontaneous firing frequency and 3) reduced the amplitude of the action potential. In addition, using voltage-clamp mode, it was possible to indicate, for the first time, that the voltage-dependent sodium current was one of the identified targets of the toxin underlying the neurotoxic effect observed in insect neurons. Therefore, in addition to being the first step in the description of the molecular diversity of Acanthoscurria spider venoms, the present work is a relevant contribution for the structural and functional characterization of a toxin belonging to the U1-TRTX-Hh1a-family. This study was funded by Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG), Financiadora de Estudos e Projetos/Ministério
da Ciência e Tecnologia Sotrastaurin in vitro (FINEP/MCT), Coordenação de aperfeiçoamento de pessoal de nível superior (CAPES), Instituto Nacional de Ciência e Tecnologia em Toxinas/Fundação
de amparo à Pesquisa do estado de São paulo (INCTTOX/FAPESP) and CNPq. The authors greatly appreciate the assistance of Mrs. Flávia De Marco in the review of the manuscript. “
“Spider venoms are an important source of bioactive molecules with applications in several areas of pharmacology (Rash and Hodgson, 2002). Tarantula (Theraphosidae) venoms contain a variety of peptides that selectively interact with ion channels (as blockers or modulators) and may be useful probes for elucidating structure–function relationships (Siemens et al., 2006; Dutertre and Lewis, 2010). Some theraphosid spider venoms can produce neuromuscular blockade in vertebrate nerve-muscle preparations in vitro ( Fontana et al., 2002; Herzig and Hodgson, 2009) and, in at least one case, the venom component responsible for Selleck Venetoclax neuromuscular blockade has been shown to be a 33-amino acid peptide, i.e., huwentoxin-I from the theraphosid Selenocosmia (now Ornithoctonus) huwena ( Liang et al., 1993; Zhou et al., 1997). Spider and wasp venoms contain (acyl)polyamines that can interact with excitatory neurotransmitter receptors, principally glutamate ionotropic receptors (Beleboni et al., 2004; Estrada et al., 2007), but also cholinergic nicotinic receptors (Anis et al., 1990; Strømgaard et al., 2005). Although tarantula venoms contain polyamines (Cabbiness et al., 1980; Skinner et al., 1990; Moore et al.